Skip to main content
BAX
NYSE Life Sciences

Baxter Slashes Oil-Price Exposure by Over 50%, Significantly Reducing Commodity and Geographic Risk

Tom Rudovsky · Reported by Wiseek News
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$18.15
Mkt Cap
$9.287B
52W Low
$17
52W High
$36.57
52W Position info
6.8% above low
Off High info
50% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

BAX is trading near its 52-week low of $17 (6.8% above the low).

Summary

Baxter International has materially de-risked its operations by cutting its oil-price exposure by over 50% since 2022, achieved through divestitures and changes to its delivery model. This strategic shift has also minimized its Middle East exposure, leading to a significant reduction in both commodity and geographic risk. This proactive measure is a positive development, especially in the context of the company's recent financial struggles, including a net loss, impairments, and credit rating downgrades reported in its latest 10-K. While Citigroup simultaneously trimmed its price target for BAX from $21 to $19, the company's efforts to enhance operational stability are a key factor for investors to monitor.

At the time of this announcement, BAX was trading at $18.15 on NYSE in the Life Sciences sector, with a market capitalization of approximately $9.3B. The 52-week trading range was $17.00 to $36.57. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

BAX - Latest Insights

BAX
Oct 29, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $22.94
Real-time Price: $26.11 info
Change: +$3.17 (+14%) info
Market Cap: $13.342B info
BAX
Oct 29, 2026, 8:06 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $26.00
Real-time Price: $26.11 info
Change: +$0.110 (+0.42%) info
Market Cap: $13.342B info
BAX
Oct 29, 2026, 7:18 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.74
Real-time Price: $26.11 info
Change: -$0.630 (-2%) info
Market Cap: $13.342B info
BAX
Oct 29, 2026, 7:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $26.50
Real-time Price: $26.11 info
Change: -$0.390 (-1%) info
Market Cap: $13.342B info
BAX
Aug 19, 2026, 8:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.20
Real-time Price: $26.11 info
Change: -$0.090 (-0.34%) info
Market Cap: $13.342B info